Minnesota Senators Launch Bid to Curb Private Equity’s Grip on Autism Therapy Amid Mounting Concerns

SAINT PAUL, MN – Following a bombshell investigation by The 74 Million, two prominent Minnesota state senators have declared their intent to introduce sweeping legislation aimed at reining in the burgeoning influence of private equity firms within the state’s autism therapy sector. The proposed laws seek to inject transparency and accountability into an industry increasingly dominated by Wall Street investors, whose profit-driven models are accused of compromising the quality of care for vulnerable autistic children.

State Senator Zaynab Mohamed (DFL-Minneapolis) minced no words in her reaction to the investigative report, stating, “This report is outrageous. The idea that Wall Street investors are exploiting these programs for profit is infuriating.” Her sentiments were echoed by fellow Democratic-Farmer-Labor Party Senator Scott Dibble, also representing Minneapolis, who emphasized the critical need for legislative intervention to protect both patients and public funds.

The legislative push comes at a crucial juncture, as national Medicaid reimbursements for Applied Behavior Analysis (ABA) – the most prevalent autism treatment – have exploded from $400 million in 2019 to nearly $2 billion in 2024. This dramatic increase is largely attributed to aggressive consolidation tactics by private equity firms, which have acquired hundreds of smaller, independent therapy centers across the nation, including a significant presence in Minnesota. Critics argue that this unchecked expansion, fueled by limited oversight, prioritizes financial returns over patient well-being, raising serious questions about the ethics and efficacy of the current system.

The Rise of Private Equity in Autism Therapy: A Chronology of Concern

The journey to this legislative proposal is rooted in a decade-long trend of financialization within the healthcare sector, now keenly observed in autism services. Private equity firms, known for their aggressive acquisition strategies and focus on short-term profits, began to eye the autism therapy market as a lucrative investment opportunity.

Early 2010s: The landscape of autism therapy was largely characterized by "mom-and-pop" operations – small, privately owned clinics often founded by passionate therapists or families. These centers, while sometimes struggling with scalability and administrative burdens, generally maintained a direct connection to patient needs and community values.

Mid-2010s: As awareness of autism grew and insurance mandates for coverage expanded, the market for autism therapy, particularly ABA, became increasingly attractive. Private equity firms, recognizing the steady revenue streams promised by government-funded programs like Medicaid and private insurance, began a systematic acquisition spree. They bought up these smaller centers, consolidating them into larger networks. This consolidation allowed them to achieve economies of scale, standardize practices (sometimes at the expense of individualized care), and, crucially, command higher reimbursement rates.

2019-2024: The "74 Million investigation" highlights this period as one of exponential growth and escalating concerns. Medicaid reimbursements for ABA surged, indicative of both increased demand and, critically, the financial engineering characteristic of private equity operations. Firms strategically moved into states like Minnesota, which offered robust Medicaid benefits and a receptive market, further concentrating their investments where the financial returns were highest.

2025: Senator Dibble’s previous legislative attempt to mandate ownership disclosure for nursing homes and assisted living facilities, though ultimately unsuccessful, foreshadowed the current concerns. His experience in the long-term care sector, where private equity ownership has been linked to declining patient care, provided a stark warning for other healthcare domains. This prior effort underscores a consistent legislative concern about transparency and accountability across healthcare services.

2026: The publication of The 74 Million’s investigation served as the immediate catalyst for Senators Mohamed and Dibble’s announcement. The report meticulously detailed the scope of private equity’s involvement and the systemic problems it created, bringing the issue to the forefront of Minnesota’s political agenda. The timing also coincides with the "One Big Beautiful Bill Act" which aims to slash Medicaid spending, adding urgency to the need for efficient and ethical allocation of resources.

Alarming Data and Questionable Practices: Supporting the Legislative Push

The evidence unearthed by The 74 Million, buttressed by broader data analyses, paints a troubling picture of an industry where financial imperatives may be overshadowing patient care.

Exploding Medicaid Costs: The most striking data point is the near five-fold increase in nationwide Medicaid reimbursements for ABA, jumping from $400 million in 2019 to almost $2 billion in 2024. This surge, while partly reflecting increased access, also suggests a system susceptible to inflated billing and aggressive utilization driven by profit motives.

Dominance of Private Equity: A rigorous analysis of U.S. Centers for Medicare and Medicaid records by The 74 revealed that private equity firms now own nearly half of the top 50 companies with the highest claims. These firms collectively accounted for a staggering $3.1 billion of the almost $7 billion billed over the six-year investigative window. This concentration of ownership by entities primarily accountable to investors, not patients, raises fundamental questions about governance and ethical responsibilities.

The Efficacy Debate and Patient Harm: Beyond the financial concerns, The 74’s reporting delved into the controversial scientific basis and potential harms associated with ABA. Often administered to autistic children as young as two for up to 40 hours a week, ABA is a behavioral conditioning treatment designed to "extinguish" autistic traits through a system of rewards and punishments.

Historically, ABA has been promoted as the "gold standard" for autism intervention. However, growing research and advocacy from the autistic community itself have challenged this narrative. Recent studies cited by The 74 have indicated heightened rates of Post-Traumatic Stress Disorder (PTSD) and psychiatric hospitalizations among individuals who underwent intensive ABA therapy in childhood. Autistic self-advocates frequently describe ABA as a deeply traumatic experience, forcing them to suppress their natural behaviors and conform to neurotypical norms, leading to long-term mental health challenges. The concern is that under private equity’s drive for efficiency and standardization, these nuanced debates about treatment efficacy and patient well-being are often sidelined.

Medicaid Fraud and Waste: The broader context of Medicaid scrutiny further underscores the urgency of reform. Scandals involving fraud and waste in Medicaid reimbursement for autism therapy have been a national issue. Minnesota, in particular, has faced criticism, even drawing the ire of the Trump administration, which cited alleged Medicaid abuse by immigrants as a justification for violent Immigration and Customs Enforcement incursions into the Twin Cities. While the administration’s claims focused on specific types of fraud, The 74’s analysis of a 275 million-record Medicaid dataset released by the Department of Government Efficiency revealed a different, systemic problem: "unchecked profiteering and lax state and federal oversight of ABA, and rapid acquisition of its providers by private equity." This highlights a distinction between individual criminal acts and a structural issue inherent in the unchecked private equity model.

Official Responses and Proposed Solutions

Senators Mohamed and Dibble are responding to these alarming findings with a clear legislative agenda focused on transparency, accountability, and patient protection. Their proposals aim to address the systemic vulnerabilities that have allowed private equity to flourish largely unregulated.

Senator Mohamed, a freshman legislator known for her advocacy for marginalized communities, articulated the ethical outrage at the core of the issue. "It is unconscionable that the well-being of our most vulnerable children is being treated as a commodity for Wall Street investors to exploit," she stated, underscoring the moral imperative behind their legislative efforts.

Senator Dibble, drawing on his experience with similar issues in the nursing home sector, outlined specific legislative priorities:

• Mandatory Ownership Transparency: At the heart of their proposal is the demand for clear and comprehensive reporting on the ownership structures of autism service centers. Dibble lamented the current obscurity, stating, "It’s not enough to have a P.O. box in New Jersey. I think we’re entitled to know — this particular entity, what else do they own, and how well have they provided services?" He drew a parallel to the rigorous vetting required for obtaining a liquor license, arguing that providers entrusted with public funds and the care of children should face even greater scrutiny. "Before someone can come in and purchase a liquor license, they need to prove that they’re an outstanding citizen who hasn’t participated in any shady practices and they can be entrusted with the public trust that a publicly issued license entails," Dibble argued, highlighting the disparity in regulatory standards.

• Weeding Out Profit-Driven Models: The senators seek to empower state regulators with the authority to scrutinize and potentially reject providers whose business models are deemed to compromise children’s care in favor of profit maximization. This could involve stringent licensing requirements and regular audits to ensure compliance with patient-centric standards.

• Minimum Spending on Patient Care: A key component of their proposed bill would require providers to dedicate a specific percentage of their Medicaid reimbursements directly to patient care. This aims to prevent excessive diversion of funds to administrative overhead, investor returns, or other non-patient-facing expenditures. "This kind of aggressive super-sized profit motive is totally inappropriate in these settings because it incentivizes behaviors that don’t support the public’s interest and good use of public dollars," Dibble emphasized.

• Enhanced Accountability Mechanisms: The lack of clarity regarding ownership makes it incredibly difficult to hold anyone accountable when patient care suffers, as critics and Senator Dibble contend. The proposed legislation would seek to establish clearer lines of responsibility, ensuring that parent companies and their executives can be held liable for substandard care or fraudulent practices, rather than allowing them to hide behind complex corporate structures.

Broader Implications for Healthcare and Vulnerable Populations

The legislative initiative in Minnesota carries significant implications, extending beyond the immediate realm of autism therapy. It touches upon fundamental questions about the role of profit in healthcare, the protection of vulnerable populations, and the future of public health policy.

Impact on Families: For families with autistic children, the consequences of unchecked private equity involvement can be devastating. When profit-driven centers prioritize efficiency over individualized care, children may receive suboptimal therapy, or worse, experience trauma. The sudden closure of centers due to financial instability, a common outcome when private equity firms extract profits and leave behind debt, can leave families scrambling to find new providers, disrupting crucial continuity of care for their children. The human cost of this disruption, stress, and potential regression in development is immeasurable.

A Precedent for Other Healthcare Sectors: Senator Dibble’s past efforts regarding nursing homes underscore that the challenges faced by autism therapy are not isolated. The private equity model, characterized by acquiring companies with stable revenue streams, extracting short-term cash, and often leaving behind debt, has mirrored what has happened in other healthcare industries. A recent investigation by state healthcare monitors in Minnesota found that 79% of complaints about abuse and neglect in long-term care facilities involved for-profit companies. The proposed legislation for autism therapy could serve as a blueprint for addressing similar issues in other sensitive healthcare sectors, setting a precedent for greater oversight of financial investors in areas critical to public welfare.

Federal and State Oversight: The Minnesota senators’ push highlights a critical gap in both state and federal oversight. While federal agencies like the Centers for Medicare and Medicaid Services (CMS) track reimbursements, the systemic issue of private equity’s impact often falls between regulatory cracks. The "One Big Beautiful Bill Act" and its focus on slashing Medicaid spending make the need for efficient and ethical allocation even more pressing. The Minnesota initiative could spur broader conversations about federal guidelines for private equity involvement in publicly funded healthcare services, potentially leading to national reforms.

The Future of Autism Therapy: The debate over private equity’s role is inextricably linked to the ongoing discussion about the future of autism therapy itself. As criticisms of ABA grow louder within the autistic community, and as newer, more neurodiversity-affirming approaches emerge, the financial entrenchment of a single, controversial therapy model by powerful corporate interests could stifle innovation and limit therapeutic choices for families. Legislation that ensures transparency and prioritizes patient outcomes over profit could create space for a more diverse and ethically sound landscape of autism support.

In conclusion, the actions of Senators Mohamed and Dibble represent a significant step towards reasserting public interest and patient welfare over unchecked corporate profiteering in a vital healthcare sector. Their proposed legislation, if successful, could not only transform autism therapy in Minnesota but also ignite a national conversation about the ethical boundaries of private equity investment in healthcare across the United States. The stakes are high, with the well-being of countless autistic children hanging in the balance.